Chinmax Medical Systems Held 2010 Biosite Products Distributor Conference; Outlook for Triage Products in China a Big Concern
The representatives also expressed concerns that the reputation of Biositeproducts and Inverness has been badly hurt in the Chinese medical market. Allthe hospitals using Biosite products in China have now become aware of thedispute involving the relevant products. Many hospitals criticized InvernessMedical Beijing's marketing behaviors, and indicated that if feasible, theywould consider replacing the relevant Triage products with those manufacturedby other competitors.
According the regulations of China's State Food and Drug Administration("SFDA"), Chinmax is the only government certified service agent for theBiosite products in China. Chinmax has been serving the Biosite products for10 years, and helped Biosite to grow its heart failure diagnostics marketshare in China from 0 to more than 80%.
Kevin Yue, General Manager of Chinmax said that, "For fairness's sake andfor our business reputation, we will pursue our infringement action againstInverness Medical Beijing to the very end."
Since 1999, Chinmax has been the exclusive distributor in China ofdiagnostics products manufactured by Biosite Incorporated, a world-leadingcardiac biomarkers company in San Diego, California, USA. Biosite was acquiredby Inverness Medical Innovations, Inc. (NYSE: IMA) in June 2007. InvernessMedical Beijing, a Chinese subsidiary of Inverness, said the company obtainedthe right to manage contracts between Biosite and Chinmax in December 2008.
SOURCE Chinmax Medical Systems, Inc.
You May Also Like